Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - OTHER CURRENT LIABILITIES
Other Current Liabilities KPTI - Karyopharm Therapeutics Inc.
86.3 M
LAST VALUE
22.61%
2 YEAR CAGR
16.78%
5 YEAR CAGR
30.52%
10 YEAR CAGR